Remdesivir Shows Promising Results as a Coronavirus Treatment, According to Drug Manufacturer Gilead
is run by the National Institute of Allergy and Infectious Diseases , part of the U.S. National Institutes of Health and involves severe patients at multiple centers across the country. Gilead has yet to release specific data from the study but noted in its release that NIAID is expected to provide more detailed results.One of these studies is designed to test remdesivir in people with moderate disease, and the other in those with more severe disease.
The results add to the growing body of data suggesting remdesivir may be effective for treating COVID-19. Remdesivir was originally designed to treat Ebola, but studies in the lab showed it also acted against coronaviruses like SARS and MERS, so researchers began exploring its potential for treating COVID-19 when the pandemic began. It works by interfering with the virus’ ability to make more copies of itself.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Cramer: Promising data from coronavirus drug trial 'beginning of the end of the true nightmare'CNBC's Jim Cramer said Wednesday that positive news from Gilead Sciences about a potential treatment for the coronavirus marked a turning point in the fight against Covid-19.
Read more »
Large coronavirus trial of drug remdesivir shows promiseRemdesivir appears to work the same in patients whether they receive five or 10 days of treatment.
Read more »
Large coronavirus trial of drug remdesivir shows promise, while another suggests no benefitRemdesivir appears to work the same in patients whether they receive five or 10 days of treatment. But another study suggested the drug has no benefit.
Read more »
Dr. Anthony Fauci says data from remdesivir coronavirus drug trial shows 'quite good news'CNBC's Meg Tirrell breaks down White House health advisor Dr. Anthony Fauci's comments on Gilead's possible coronavirus treatment.
Read more »
Regeneron, Sanofi arthritis drug may only help critical coronavirus patients: studyResults of a study of Regeneron Pharmaceuticals Inc and Sanofi SA's rheumatoid arthritis drug Kevzara indicate it may only help the sickest coronavirus patients, the companies said on Monday, dampening hopes the medicine could benefit a wider group of those infected.
Read more »
Why a Common Heartburn Drug Is Being Studied as a Possible Coronavirus TreatmentWhy a Heartburn Drug Is Being Studied as a COVID-19 Treatment, According to Doctors
Read more »